Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma

Cancer Drug Resistance · Published 2026-05-19 · DOI 10.20517/cdr.2026.27

Free full text

Authors (8)

Yujia Zhang, Yicheng Zhu, Zichang Liu, Haonan Li, Bingxu Zhong, Xingang Cui, Yan Kong, Hui Lu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, Y., Zhu, Y., Liu, Z., et al. (2026). Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma. Cancer Drug Resistance. https://doi.org/10.20517/cdr.2026.27

Related articles

• BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study · Cancer Immunology, Immunotherapy · 2023 · Cites or is cited by this article
• KLF5 promotes tumor proliferation and oxaliplatin resistance via chromatin remodeling in KRAS-mutated colorectal cancer · Cancer Drug Resistance · 2025 · Same journal
• Immunotherapy resistance and strategies in malignant pleural mesothelioma · Cancer Drug Resistance · 2026 · Same journal
• Effects of FAP+ cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4+ T cell polarization in gastric cancer · Cancer Drug Resistance · 2025 · Same journal
• TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells · Cancer Drug Resistance · 2026 · Same journal
• Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance · Cancer Drug Resistance · 2026 · Same journal
• Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy · Cancer Drug Resistance · 2026 · Same journal
• Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update · Cancer Drug Resistance · 2025 · Same journal
• Corosolic acid increases the therapeutic effect of cisplatin on gastric cancer by regulating Gpx4-dependent ferroptosis · Cancer Drug Resistance · 2025 · Same journal
• ROS1 mutations promote an immunosuppressive tumor microenvironment via MYC to confer immune evasion in head and neck cancer · Cancer Drug Resistance · 2025 · Same journal